Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

NCT07715617 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT07715617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07715617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Recruiting
Start date
February 16, 2026
Completion date
March 16, 2031
Enrollment
230 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-1-antitrypsin deficiency, artificial intelligence (ai), emphysema, lung transplantation, mortality prediction, predictive learning models